دورية أكاديمية

[Haploidentical transplantation from a related donor as first-line treatment for fulminant aplastic anemia].

التفاصيل البيبلوغرافية
العنوان: [Haploidentical transplantation from a related donor as first-line treatment for fulminant aplastic anemia].
المؤلفون: Makishima K; Department of Hematology, University of Tsukuba Hospital., Obara N; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Sakamoto T; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Kato T; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Kusakabe M; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Nishikii H; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Kurita N; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Yokoyama Y; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Sakata-Yanagimoto M; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Hasegawa Y; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba., Chiba S; Department of Hematology, University of Tsukuba Hospital.; Department of Hematology, Faculty of Medicine, University of Tsukuba.
المصدر: [Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2020; Vol. 61 (10), pp. 1464-1468.
نوع المنشور: Case Reports; Journal Article
اللغة: Japanese
بيانات الدورية: Publisher: Japan Society Of Clinical Hematology Country of Publication: Japan NLM ID: 2984782R Publication Model: Print Cited Medium: Print ISSN: 0485-1439 (Print) Linking ISSN: 04851439 NLM ISO Abbreviation: Rinsho Ketsueki Subsets: MEDLINE
أسماء مطبوعة: Publication: Tokyo : Japan Society Of Clinical Hematology
Original Publication: Tokyo, Rinsho Ketsueki Kondankai.
مواضيع طبية MeSH: Anemia, Aplastic*/therapy , Graft vs Host Disease* , Hematopoietic Stem Cell Transplantation*, Adult ; Granulocyte Colony-Stimulating Factor ; Humans ; Male ; Transplantation Conditioning ; Transplantation, Haploidentical
مستخلص: Immunosuppressive therapy (IST) is the first-line treatment for young patients with severe aplastic anemia (AA) when a human leucocyte antigen (HLA)-matched related donor (MRD) is unavailable. Fulminant AA (FAA) is defined as AA with a complete absence of neutrophils at presentation and no response to granulocyte-colony stimulating factor (G-CSF) treatment. Here we report a 38-year-old male FAA patient who underwent allogeneic stem cell transplantation from an HLA haplotype-mismatched donor as first-line treatment. The patient had no remarkable disease history and was referred to our hospital because of a peritonsillar abscess and severe pancytopenia. Bone marrow biopsy revealed marked hypocellularity without dysplasia. His neutrophil count remained 0.0×10 9 /l following G-CSF administration, and he was diagnosed with FAA. His siblings were not MRDs, but his sister had haploidentical HLAs. After administering a conditioning regimen, the patient received a transplant of peripheral blood stem cells donated by his sister. Neutrophil engraftment was observed on post-transplant day 16, and he experienced acute graft-versus-host disease (grade I, skin stage 1), but no other complications were observed. Hematopoietic stem cell transplantation from an HLA haplotype-mismatched related donor may be a viable option for first-line treatment of FAA when an MRD is unavailable.
فهرسة مساهمة: Keywords: Fulminant aplastic anemia; HLA haplotype-mismatch; Haploidentical transplantation; Hematopoietic stem cell transplantation
المشرفين على المادة: 143011-72-7 (Granulocyte Colony-Stimulating Factor)
تواريخ الأحداث: Date Created: 20201109 Date Completed: 20210114 Latest Revision: 20210114
رمز التحديث: 20221213
DOI: 10.11406/rinketsu.61.1464
PMID: 33162441
قاعدة البيانات: MEDLINE
الوصف
تدمد:0485-1439
DOI:10.11406/rinketsu.61.1464